We demonstrated that DNMT inhibition can potently inhibit the STAT3-DNA methylation pathway in both CD8+ T cells of LGLL patients and KAI3 NK cells expressing activating STAT3 variants. The gene discussed is STAT3; the disease is T-cell large granular lymphocyte leukemia.